

What is Tivicay? Learn about this HIV medication's uses, dosage, how to take it, side effects, cost, and everything you need to know in 2026.
Tivicay is the brand name for Dolutegravir, a prescription medication used to treat HIV-1 infection. It belongs to a class of drugs called integrase strand transfer inhibitors (INSTIs). Tivicay is made by ViiV Healthcare, a company owned by GSK that focuses exclusively on HIV treatments.
Tivicay is not a cure for HIV. Instead, it works by blocking the virus from multiplying in your body. When taken correctly as part of a combination regimen, Tivicay can reduce your viral load to undetectable levels — meaning the virus is still present but at such low levels that standard tests can't detect it. An undetectable viral load also means you cannot transmit HIV to sexual partners (known as U=U, or Undetectable = Untransmittable).
Tivicay is FDA-approved for the treatment of HIV-1 infection in:
Tivicay is always used in combination with other HIV medications. It is never taken alone. Common combination partners include tenofovir and emtricitabine, or lamivudine. Tivicay is also a key ingredient in several combination pills:
If you're taking one of these combination products, you're already getting Dolutegravir — you don't need separate Tivicay.
The standard dosages for Tivicay are:
50 mg once daily — This is the most common dose. One tablet, once a day.
50 mg twice daily — If resistance testing shows your HIV has mutations that reduce sensitivity to integrase inhibitors, your doctor may increase the dose.
50 mg twice daily — Some medications speed up how your body breaks down Dolutegravir, reducing its effectiveness. If you take any of the following, your doctor will likely prescribe 50 mg twice daily:
For a complete list of medications that interact with Tivicay, read our guide on Tivicay drug interactions.
As of 2024, only the 50 mg film-coated tablet is available for adults. The 10 mg and 25 mg tablets were permanently discontinued in January 2024. Tivicay PD (5 mg dispersible tablets) remains available for pediatric patients.
Follow these guidelines for taking Tivicay:
Tivicay blocks a specific HIV enzyme called integrase. Normally, HIV uses integrase to insert its genetic material into your cells' DNA, which allows the virus to hijack your cells and make copies of itself. By blocking this step, Tivicay prevents the virus from replicating.
For a more detailed explanation, read How Does Tivicay Work? Mechanism of Action Explained.
Most people tolerate Tivicay well. The most commonly reported side effects include:
These side effects are usually mild and often improve within the first few weeks of treatment. Serious side effects are rare but can include hypersensitivity reactions, liver problems, weight gain, and elevated creatine kinase.
For a complete breakdown, read Tivicay Side Effects: What to Expect.
Tivicay is not for everyone. You should not take it if you:
Talk to your doctor before taking Tivicay if you have liver disease, are pregnant or planning to become pregnant, or take any other medications.
Tivicay is an expensive brand-name medication:
There is currently no generic version of Tivicay available in the United States. Generic Dolutegravir is expected to become available after Tivicay's patent expires in June 2030.
For more ways to reduce your costs, read How to Save Money on Tivicay.
How does Tivicay compare to other options?
Your doctor will recommend the best option based on your treatment history, resistance testing, other medications, and preferences. Learn more in our alternatives to Tivicay guide.
While Tivicay is not currently listed on national shortage databases, it can sometimes be difficult to find at your local pharmacy. The 10 mg and 25 mg strengths were discontinued in 2024, and specialty distribution can cause intermittent availability issues.
If you're having trouble finding Tivicay:
Tivicay is a proven, effective HIV medication that has helped millions of people achieve and maintain an undetectable viral load. It's taken once daily (for most patients), has a manageable side effect profile, and is a cornerstone of modern HIV treatment. While the cost is high and a generic won't be available until 2030, savings programs can significantly reduce what you pay.
If you need help finding Tivicay or want to compare pharmacy prices, visit MedFinder.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.